New Market Research Report: Exosomics Siena SpA - Product Pipeline Analysis, 2013 Update

From: Fast Market Research, Inc.
Published: Mon Dec 16 2013

Exosomics Siena SpA (Exosomics) is a biotechnology company. It focuses on developing proprietary platforms for exosome based cancer diagnostics and companion diagnostics. The company carries out applied research, and research and development activities in the area of exosome associated biomarkers. Its technology is used in developing immunometric multiplexing assays and point of care devices for diagnosis of major tumors and cancer screening. The company offers services such as contract research, collaborative projects, apply exosomes to leads, and technical services to biotech and pharmaceutical R&D organizations. It has collaborations with academic and industrial research groups to develop a panel of proprietary biomarkers and also develop its technological platforms. The company is a spin of HansaBioMed OU. Exosomics is headquartered in Siena, Tuscany, Italy.

Full Report Details at

This report is a source for data, analysis and actionable intelligence on the Exosomics Siena SpA portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.


* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- XEPTAGEN SpA - Product Pipeline Analysis, 2013 Update
- AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2013 Update
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Medtronic, Inc. (MDT) - Product Pipeline Analysis, 2013 Update
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »